Semaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes. It works by increasing insulin secretion and decreasing glucagon levels, improving blood sugar control. Semaglutide's clinical relevance lies in its ability to manage diabetes effectively. In summary, Semaglutide is a vital option for diabetes management.
Semaglutide activates GLP-1 receptors, enhancing insulin secretion and suppressing glucagon release in response to elevated blood glucose levels.